Search Results for user fee goal dates for meetings

Showing 1 – 1

Formal Meetings Between FDA and Biopharma Companies: New Draft Guidance By Zachary Brennan - Published 02 January 2018

Know the difference between a Type A, Type B and Type C meeting with the US Food and Drug Administration (FDA)? New draft guidance released last week will help biopharma companies understand how to conduct such meetings and what to expect.

Categories: News, US, FDA, Biologics and biotechnology, Drugs, Government affairs, Research and development

Tags: formal FDA meetings, PDUFA VI, user fee goal dates for meetings, Type A meeting